38 results
8-K
EX-99.1
ACGN
Aceragen Inc
6 Nov 18
Idera Pharmaceuticals Reports Third Quarter 2018 Financial Results and Provides Corporate Update
5:01pm
refractory/relapsed metastatic melanoma:
Ipilimumab Combination Arm — Phase 2 Recruitment Ongoing
· Enrollment continues at 10 U.S. clinical trial
8-K
EX-99.1
5x20za2
5 Nov 09
Idera Pharmaceuticals Reports Third Quarter 2009 Financial Results and Provides Pipeline Update
12:00am
CORRESP
t469lvag ixmkzb
26 Sep 06
Correspondence with SEC
12:00am